1989
DOI: 10.1007/bf01995853
|View full text |Cite
|
Sign up to set email alerts
|

Transient gall bladder dilatation associated with hypokalaemia in a patient with Bartter syndrome

Abstract: A 5.5-month-old male infant with hypokalaemia and gall bladder dilatation is reported. The child was shown to have Bartter syndrome. After oral treatment with potassium and indomethacin, serum potassium levels became low normal and the gall bladder enlargement resolved. This entity should be included in the clinical spectrum of neuromuscular disturbances resulting from hypokalaemia and should be considered in a hypokalaemic infant with a right-sided abdominal mass.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1992
1992
2015
2015

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…We are hesitant to extrapolate the behaviour of hepatoma cells given an EPA-predominant fatty acid environment in culture to hepatic function in intact subjects for whom maximal plasma levels of EPA, as well as its proportion of the plasma NEFA pool, are considerably lower. Nevertheless, we are concerned that antiproliferative effects of n -3 PUFAs have been observed in vivo [58,59], and that fish-oil treatment is finding its way into paediatric use [75]. Until the effects of fishoil n -3 PUFAs on hepatocyte proliferation are better understood, perhaps they should be administered cautiously in clinical situations where continued hepatic growth or regeneration is desirable.…”
Section: Discussionmentioning
confidence: 99%
“…We are hesitant to extrapolate the behaviour of hepatoma cells given an EPA-predominant fatty acid environment in culture to hepatic function in intact subjects for whom maximal plasma levels of EPA, as well as its proportion of the plasma NEFA pool, are considerably lower. Nevertheless, we are concerned that antiproliferative effects of n -3 PUFAs have been observed in vivo [58,59], and that fish-oil treatment is finding its way into paediatric use [75]. Until the effects of fishoil n -3 PUFAs on hepatocyte proliferation are better understood, perhaps they should be administered cautiously in clinical situations where continued hepatic growth or regeneration is desirable.…”
Section: Discussionmentioning
confidence: 99%
“…Abdominal pain, vomiting, and RUQ mass in abdominal examination are the typical presentations of gallbladder hydrops. Kawasaki syndrome ( 5 ), mesenteric adenitis with pressure over cystic duct ( 5 ), streptococcal and staphylococcal infections with the associated toxin production ( 6 ), viral hepatitis, Henoch-Schoenlein purpura ( 7 ) and hypokalemia ( 8 ) had reported association with hydrops of gallbladder. Other etiologies include tumors, polyps or malignancy of the gallbladder, spontaneously resolved acute cholecystitis, congenital narrowing of the cystic duct, parasites such as ascaris (occasionally), prolonged parenteral nutrition, typhoid, leptospirosis, and appropriate response to ceftriaxone therapy ( 1 ).…”
Section: Discussionmentioning
confidence: 99%